查看完整行情页>>
|
货币单位:美元(USD)
神经分泌生物科学
Neurocrine Biosciences, Inc. (nbix)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Deerfield Management Co |
1657800 |
1.73% |
279855 |
20.31% |
2022-03-31
|
| State Street Corporation |
3734170 |
3.91% |
7029 |
0.19% |
2022-03-31
|
| FMR LLC |
3780076 |
3.96% |
-4656553 |
-55.19% |
2021-07-30
|
| T. Rowe Price Associates, Inc. |
4288770 |
4.49% |
-70875 |
-1.63% |
2022-03-31
|
| Janus Capital Management LLC |
5566813 |
5.82% |
-1902547 |
-25.47% |
2022-05-31
|
| HHG PLC |
6309763 |
6.60% |
-1136076 |
-15.26% |
2022-03-31
|
| Vanguard Group Inc |
8777458 |
9.18% |
-10533 |
-0.12% |
2022-03-31
|
| BlackRock Fund Advisors |
10598406 |
11.09% |
32159 |
0.30% |
2022-05-31
|
| BlackRock Inc |
11476545 |
12.01% |
1258312 |
12.31% |
2021-12-31
|
| Bellevue Asset Management AG |
3029051 |
3.17% |
-385697 |
-11.30% |
2022-05-31
|
| Bellevue Group AG |
3023451 |
3.16% |
-157100 |
-4.94% |
2022-03-31
|
| Bank of New York Mellon Corp |
1703093 |
1.78% |
-158896 |
-8.53% |
2022-03-31
|
| Fidelity Management & Research Company LLC |
1827462 |
1.91% |
-2108917 |
-53.58% |
2022-05-31
|
| SSGA Funds Management Inc |
1861615 |
1.95% |
132569 |
7.67% |
2022-05-31
|
| J.P. Morgan Investment Management, Inc. |
2157894 |
2.26% |
371046 |
20.77% |
2022-05-31
|
| Janus Henderson Investors |
2319616 |
2.43% |
-135654 |
-5.53% |
2022-05-31
|
| Goldman Sachs Asset Management, L.P. |
2701559 |
2.83% |
126188 |
4.90% |
2022-05-31
|
| Vanguard Investments Australia Ltd |
2810529 |
2.94% |
16825 |
0.60% |
2022-05-31
|
| JPMorgan Chase & Co |
3005309 |
3.14% |
24210 |
0.81% |
2022-03-31
|
| Eaton Vance Management |
1846915 |
1.93% |
-38991 |
-2.07% |
2021-12-31
|
| CAPITAL INTERNATIONAL INVESTORS |
4049442 |
4.24% |
4049442 |
-- |
2020-12-31
|
| FMR Inc |
3465147 |
3.65% |
-763211 |
-18.05% |
2021-09-30
|
| DSM Capital Partners LLC |
1513110 |
1.59% |
-22374 |
-1.46% |
2021-09-30
|
| Goldman Sachs Group Inc |
1443498 |
1.52% |
20210 |
1.42% |
2021-09-30
|
| Pictet Asset Management Ltd |
1722709 |
1.82% |
160186 |
10.25% |
2021-06-30
|
| Perceptive Advisors LLC |
1623664 |
1.71% |
681832 |
72.39% |
2021-06-30
|
| Fidelity SelectCo, LLC |
1746090 |
1.84% |
-1072380 |
-38.05% |
2021-10-31
|
| Capital Research and Management Company |
2128766 |
2.25% |
-1604510 |
-42.98% |
2021-09-30
|
| Fidelity Management and Research Company |
7014127 |
7.41% |
-1136552 |
-13.94% |
2021-03-31
|
| Capital Research & Mgmt Co - Division 3 |
1572326 |
1.66% |
-1840323 |
-53.93% |
2021-03-31
|
| Rock Springs Capital Management LP |
1575000 |
1.67% |
109500 |
7.47% |
2020-12-31
|
| Renaissance Technologies Corp |
1807191 |
1.91% |
-342273 |
-15.92% |
2020-12-31
|
| Capital Group |
2974246 |
3.15% |
-609129 |
-17.00% |
2021-03-31
|
| Amvescap Plc. |
1733473 |
1.85% |
-219836 |
-11.25% |
2020-09-30
|
| Capital Research & Mgmt Co - Division 3 |
4275476 |
4.58% |
-1820920 |
-29.87% |
2020-09-30
|
| Fidelity Management & Research Company LLC |
5978285 |
6.40% |
-743177 |
-11.06% |
2020-11-30
|
| Franklin Resources Inc |
1677681 |
1.80% |
-305818 |
-15.42% |
2020-03-31
|
| Franklin Advisers, Inc. |
1677220 |
1.83% |
-306181 |
-15.44% |
2020-03-31
|
| Fidelity Management & Research Company |
5450576 |
5.95% |
-789543 |
-12.65% |
2020-05-31
|
| Healthcor Management LP |
1547740 |
1.69% |
740876 |
91.82% |
2020-03-31
|
| Geode Capital Management, LLC |
2070460 |
2.26% |
1087282 |
110.59% |
2019-12-31
|
| Pictet Asset Management SA (Junked) |
2082000 |
2.27% |
1132310 |
119.23% |
2019-09-30
|
| Orbimed Advisors, LLC |
1575170 |
1.72% |
-258030 |
-14.08% |
2019-09-30
|
| Deutsche Asset Management Investment GmbH |
3158974 |
3.46% |
2397167 |
314.67% |
2019-05-31
|
| Artisan Partners Limited Partnership |
1672187 |
1.84% |
-165077 |
-8.98% |
2018-12-31
|
| Fidelity Institutional Asset Management |
1435253 |
1.58% |
-31949 |
-2.18% |
2018-09-30
|
| Invesco Advisers, Inc |
1908941 |
2.11% |
-285534 |
-13.01% |
2018-06-30
|
| BlackRock Institutional Trust Company NA |
2395891 |
2.64% |
-47509 |
-1.94% |
2018-06-30
|
| Wellington Management Company LLP |
2405500 |
2.65% |
33827 |
1.43% |
2018-06-30
|
| Franklin Advisers Inc |
1825386 |
2.02% |
-531200 |
-22.54% |
2018-06-30
|
| State Street Corp |
1774067 |
1.96% |
-149001 |
-7.75% |
2018-06-30
|
| TimesSquare Capital Management, LLC |
1481612 |
1.64% |
-318450 |
-17.69% |
2018-06-30
|
| AllianceBernstein LP |
1164900 |
1.29% |
-82597 |
-6.62% |
2018-06-30
|
| Wells Capital Management Inc. |
1009144 |
1.12% |
103368 |
11.41% |
2018-06-30
|
| First Trust Advisors L.P. |
979671 |
1.08% |
52200 |
5.63% |
2018-06-30
|
| Baker Bros Advisors LP |
944624 |
1.04% |
-- |
-- |
2018-06-30
|
| Point72 Asset Management, L.P. |
895900 |
0.99% |
820900 |
1094.53% |
2018-06-30
|
| Pictet Asset Management SA |
939871 |
1.05% |
-180790 |
-16.13% |
2018-03-31
|
| Goldman, Sachs & Co. |
921517 |
1.03% |
-325185 |
-26.08% |
2018-03-31
|
| Goldman Sachs Asset Management LP |
1005549 |
1.14% |
-118535 |
-10.55% |
2017-09-30
|
| Arrowpoint Asset Management, LLC |
887946 |
1.00% |
-7633 |
-0.85% |
2017-09-30
|
| Eagle Asset Management, Inc. |
914500 |
1.05% |
-27153 |
-2.88% |
2016-09-30
|
| BlackRock Advisors LLC |
943190 |
1.09% |
-17066 |
-1.78% |
2016-09-30
|
| OppenheimerFunds Inc |
1002548 |
1.15% |
170680 |
20.52% |
2016-09-30
|
| Citadel Advisors Llc |
1037519 |
1.19% |
103974 |
11.14% |
2016-09-30
|
| Senator Investment Group LP |
1150000 |
1.32% |
300000 |
35.29% |
2016-09-30
|
| Westfield Capital Management Company, LP |
1255995 |
1.45% |
-19580 |
-1.53% |
2016-09-30
|
| Capital World Investors |
1481000 |
1.70% |
-- |
-- |
2016-09-30
|
| BlackRock, Inc. |
6347260 |
3.00% |
259983770 |
0.10% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| American Century Heritage Fund |
601442 |
0.63% |
601442 |
-- |
2022-03-31
|
| BB Biotech AG |
2865400 |
3.00% |
-150000 |
-4.97% |
2022-03-31
|
| Vanguard Total Stock Market Index Fund |
2764118 |
2.89% |
17633 |
0.64% |
2022-04-30
|
| iShares Core S&P Mid-Cap ETF |
2727963 |
2.85% |
2212 |
0.08% |
2022-05-31
|
| Vanguard Small Cap Index |
2390434 |
2.50% |
2421 |
0.10% |
2022-04-30
|
| Janus Henderson Enterprise Fund |
1581538 |
1.65% |
-- |
-- |
2022-03-31
|
| Janus Mid Cap Growth Tr |
1581538 |
1.65% |
-- |
-- |
2022-03-31
|
| T. Rowe Price Mid-Cap Growth Fund |
1455800 |
1.52% |
-1800 |
-0.12% |
2022-03-31
|
| Vanguard Small Cap Growth Index Fund |
1441020 |
1.51% |
-554 |
-0.04% |
2022-04-30
|
| Vanguard Extended Market Index Fund |
1255919 |
1.31% |
-456 |
-0.04% |
2022-04-30
|
| Janus Henderson Triton Fund |
1149748 |
1.20% |
-56626 |
-4.69% |
2022-03-31
|
| iShares S&P Mid-Cap 400 Growth ETF |
634474 |
0.66% |
-987 |
-0.16% |
2022-05-31
|
| Janus Henderson Global Life Sciences Fd |
688363 |
0.72% |
-14242 |
-2.03% |
2022-04-30
|
| Janus Global Life Science Fund |
706661 |
0.74% |
-82898 |
-10.50% |
2022-03-31
|
| iShares Biotechnology ETF |
711088 |
0.74% |
-8689 |
-1.21% |
2022-05-31
|
| SPDR |
735725 |
0.77% |
24840 |
3.49% |
2022-05-31
|
| Janus Henderson Global Life Science |
762718 |
0.80% |
-77047 |
-9.17% |
2022-03-31
|
| Janus Henderson US SMID Cap Growth |
1149748 |
1.20% |
-56626 |
-4.69% |
2022-03-31
|
| Janus Henderson US Opportunistic Alpha |
628123 |
0.66% |
-223193 |
-26.22% |
2021-12-31
|
| Janus Henderson Contrarian Fund |
628123 |
0.66% |
-223193 |
-26.22% |
2021-12-31
|
| First Trust NYSE Arca Biotech Fund |
635124 |
0.66% |
-- |
-- |
2022-03-31
|
| Janus Henderson Research Fund |
961038 |
1.01% |
-106859 |
-10.01% |
2021-09-30
|
| Janus Henderson US Research Growth Eq |
961038 |
1.01% |
-106859 |
-10.01% |
2021-09-30
|
| Fidelity Advisor |
754270 |
0.80% |
-600932 |
-44.34% |
2021-10-31
|
| Capital Group Growth Fnd of Amer Comp |
894405 |
0.94% |
-336131 |
-27.32% |
2021-06-30
|
| American Funds Growth Fund of Amer |
894405 |
0.94% |
-336131 |
-27.32% |
2021-06-30
|
| T. Rowe Price New Horizons Fund |
860649 |
0.91% |
-254300 |
-22.81% |
2021-03-31
|
| T. Rowe Price Health Sciences Fund |
1017221 |
1.08% |
-62275 |
-5.77% |
2020-12-31
|
| Fidelity |
1000000 |
1.06% |
-- |
-- |
2021-01-31
|
| iShares Nasdaq Biotechnology ETF |
807429 |
0.86% |
-5990 |
-0.74% |
2021-01-29
|
| Capital Group Fundamental Invtrs Comp |
924135 |
0.99% |
-85073 |
-8.43% |
2020-09-30
|
| American Funds Fundamental Invs |
924135 |
0.99% |
-85073 |
-8.43% |
2020-09-30
|
| BlackRock Health Sciences Opps Port |
612447 |
0.67% |
-16153 |
-2.57% |
2020-03-31
|
| Worldwide Healthcare |
646600 |
0.71% |
-- |
-- |
2019-07-31
|
| DWS Verm |
1680000 |
1.84% |
1260000 |
300.00% |
2019-04-30
|
| Vanguard Small Cap Index Fund |
2372517 |
2.60% |
15166 |
0.64% |
2019-04-30
|
| VA CollegeAmerica The Gr Fd of Amer |
2738000 |
3.01% |
2738000 |
-- |
2018-12-31
|
| Artisan Mid Cap Fund |
674514 |
0.74% |
-- |
-- |
2018-10-31
|
| Franklin Biotechnology Discovery Fund |
649305 |
0.72% |
151300 |
30.38% |
2018-11-30
|
| iShares Nasdaq Biotechnology |
1019947 |
1.12% |
-1941 |
-0.19% |
2018-09-12
|
| Vanguard Small Cap Growth Index Inv |
1291418 |
1.43% |
18334 |
1.44% |
2018-07-31
|
| Janus Enterprise D |
1825633 |
2.02% |
-- |
-- |
2018-06-30
|
| Vanguard Total Stock Mkt Idx |
2255500 |
2.49% |
2346 |
0.10% |
2018-07-31
|
| T. Rowe Price Health Sciences |
2350166 |
2.60% |
-35742 |
-1.50% |
2018-06-30
|
| Vanguard Extended Market Idx Inv |
1191667 |
1.32% |
-- |
-- |
2018-07-31
|
| Hartford MidCap A |
1187436 |
1.31% |
-133846 |
-10.13% |
2018-07-31
|
| T. Rowe Price New Horizons |
1788746 |
1.98% |
-157063 |
-8.07% |
2018-06-30
|
| Artisan Mid Cap Investor |
732194 |
0.81% |
-67299 |
-8.42% |
2018-06-30
|
| Janus Global Life Sciences D |
787513 |
0.87% |
-68721 |
-8.03% |
2018-06-30
|
| First Trust NYSE Arca Biotech ETF |
718040 |
0.78% |
-- |
-- |
2018-09-13
|
| Janus Triton D |
889607 |
0.98% |
-- |
-- |
2018-06-30
|
| Janus Research D |
1140748 |
1.26% |
-- |
-- |
2018-06-30
|
| VA CollegeAmerica Smcap World 529E |
658000 |
0.73% |
-30000 |
-4.36% |
2018-06-30
|
| Delaware Smid Cap Growth A |
597225 |
0.66% |
26125 |
4.57% |
2018-05-31
|
| Invesco Mid Cap Growth A |
645904 |
0.72% |
-132041 |
-16.97% |
2018-03-31
|
| Invesco Mid Cap Growth |
645904 |
0.72% |
635644 |
6195.36% |
2018-03-31
|
| Franklin Biotechnology Discovery A |
740100 |
0.83% |
-158300 |
-17.62% |
2017-12-31
|
| T. Rowe Price Mid-Cap Growth |
850000 |
0.98% |
850000 |
-- |
2016-09-30
|
| Janus Global Life Sciences Fund |
898044 |
1.10% |
-121463 |
-11.90% |
2015-09-30
|
| VA CollegeAmerica Small Cap World |
927500 |
1.10% |
-170200 |
-15.50% |
2015-09-30
|
| Fidelity® OTC Portfolio |
984200 |
1.10% |
345747 |
54.10% |
2015-09-30
|
| Fidelity® Select Health Care Portfolio |
1100000 |
1.30% |
-- |
-- |
2015-09-30
|
| iShares Russell 2000 (AU) |
1352605 |
1.70% |
-1704 |
-0.10% |
2015-11-19
|
| Fidelity® Contrafund® Fund |
2136614 |
2.50% |
325855 |
18.00% |
2015-09-30
|
| Fidelity® Select Biotechnology Portfolio |
3582851 |
4.20% |
-- |
-- |
2015-09-30
|
